The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programsMise à jour 2010 des Lignes directrices de la Société canadienne de cardiologie sur le diagnostic et la prise en charge de l’insuffisance cardiaque : Insuffisance cardiaque dans les populations des minorités ethniques, insuffisance cardiaque et grossesse, prise en charge de la maladie et programmes d’amélioration et d’assurance de la qualité

https://doi.org/10.1016/S0828-282X(10)70367-6Get rights and content

Since 2006, the Canadian Cardiovascular Society heart failure (HF) guidelines have published annual focused updates for cardiovascular care providers. The 2010 Canadian Cardiovascular Society HF guidelines update focuses on an increasing issue in the western world – HF in ethnic minorities – and in an uncommon but important setting – the pregnant patient. Additionally, due to increasing attention recently given to the assessment of how care is delivered and measured, two critically important topics – disease management programs in HF and quality assurance – have been included. Both of these topics were written from a clinical perspective. It is hoped that the present update will become a useful tool for health care providers and planners in the ongoing evolution of care for HF patients in Canada.

Depuis 2006, la Société canadienne de cardiologie publie chaque année une mise à jour de ses Lignes directrices sur l’insuffisance cardiaque (IC) ciblées, à l’intention des professionnels de la santé cardiovasculaire. La mise à jour 2010 des Lignes directrices de la Société canadienne de cardiologie sur l’IC porte sur un problème croissant en Occident, l’insuffisance cardiaque chez les minorités ethniques, et sur un tableau rare mais important, l’insuffisance cardiaque chez la femme enceinte. En outre, comme on accorde depuis peu une plus grande attention à l’évaluation de la façon dont les soins sont prodigués et évalués, deux autres sujets d’une grande importance sont abordés : les programmes de prise en charge de l’IC et l’assurance de la qualité. Ces deux derniers volets ont été rédigés d’un point de vue clinique. Il est à espérer que la présente mise à jour deviendra un outil pratique pour les professionnels de la santé et les planificateurs, compte tenu de l’évolution constante des soins prodigués aux patients atteints d’IC au Canada.

References (196)

  • C.W. Yancy

    HF in African Americans: A cardiovascular engima

    J Card Fail

    (2000)
  • S. Goldstein et al.

    Metoprolol CR/XL in black patients with HF (from the Metoprolol CR/XL randomized intervention trial in chronic HF)

    Am J Cardiol

    (2003)
  • P. Carson et al.

    Racial differences in response to therapy for HF: Analysis of the vasodilator-HF trials. Vasodilator-HF Trial Study Group

    J Card Fail

    (1999)
  • S.S. Anand et al.

    Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: The Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP)

    Lancet

    (2001)
  • A. Fagot-Campagna et al.

    Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective

    J Pediatr

    (2000)
  • W.E. Hoy et al.

    A chronic disease outreach program for Aboriginal communities

    Kidney Int Suppl

    (2005)
  • S.L. Clark et al.

    Central hemodynamic assessment of normal term pregnancy

    Am J Obstet Gynecol

    (1989)
  • E.L. Capeless et al.

    Cardiovascular changes in early phase of pregnancy

    Am J Obstet Gynecol

    (1989)
  • W. Lee

    Cardiorespiratory alterations during normal pregnancy

    Crit Care Clin

    (1991)
  • J.J. Duvekot et al.

    Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone

    Am J Obstet Gynecol

    (1993)
  • N.F. Gant et al.

    Control of vascular responsiveness during human pregnancy

    Kidney Int

    (1980)
  • N.A. Kametas et al.

    Maternal cardiac function in twin pregnancy

    Obstet Gynecol

    (2003)
  • A.C. Van Oppen et al.

    Cardiac output in normal pregnancy: A critical review

    Obstet Gynecol

    (1996)
  • W.C. Mabie et al.

    A longitudinal study of cardiac output in normal human pregnancy

    Am J Obstet Gynecol

    (1994)
  • R. Cutforth et al.

    Heart sounds and murmurs in pregnancy

    Am Heart J

    (1966)
  • O. Campos et al.

    Physiologic multivalvular regurgitation during pregnancy: A longitudinal Doppler echocardiographic study

    Int J Cardiol

    (1993)
  • J.L. Resnik et al.

    Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women

    Am J Obstet Gynecol

    (2005)
  • A.H. Kovacs et al.

    Pregnancy and contraception in congenital heart disease: What women are not told

    J Am Coll Cardiol

    (2008)
  • M. Pirlet et al.

    Low dose combined spinal-epidural anaesthesia for caesarean section in a patient with peripartum cardiomyopathy

    Int J Obstet Anesth

    (2000)
  • A. Pryn et al.

    Cardiomyopathy in pregnancy and casesarean section: Four case reports

    Int J Obstet Anesth

    (2007)
  • D.P. Dob et al.

    Practical management of the parturient with congenital heart disease

    Int J Obstet Anesth

    (2006)
  • L.M. Mielniczuk et al.

    Frequency of peripartum cardiomyopathy

    Am J Cardiol

    (2006)
  • B.D. Bultmann et al.

    High prevalence of viral genomes and inflammation in peripartum cardiomyopathy

    Am J Obstet Gyn

    (2005)
  • Canada's ethnocultural mosaic in 2006

    (2008)
  • E. Rideout et al.

    Hope, morale and adaptation in patients with chronic HF

    J Adv Nurs

    (1986)
  • A.A. Ajayi et al.

    Enalapril in African patients with congestive cardiac failure

    Br J Clin Pharmacol

    (1989)
  • R. Balarajan

    Ethnicity and health: The challenges ahead

    Ethn Health

    (1996)
  • S. Wild et al.

    Cross sectional analysis of mortality by country of birth in England and Wales, 1970–92

    BMJ

    (1997)
  • T. Sheth et al.

    Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: An analysis of 1.2 million deaths

    CMAJ

    (1999)
  • P.M. Kearney et al.

    Worldwide prevalence of hypertension: A systematic review

    J Hypertens

    (2004)
  • H. Ueshima et al.

    Epidemiology of hypertension in China and Japan

    J Hum Hypertens

    (2000)
  • H.M. Blackledge et al.

    Prognosis for South Asian and white patients newly admitted to hospital with HF in the United Kingdom: Historical cohort study

    BMJ

    (2003)
  • J.D. Newton et al.

    Ethnicity and variation in prognosis for patients newly hospitalised for HF: A matched historical cohort study

    Heart

    (2005)
  • N. Singh et al.

    Clinical characteristics of South Asian patients hospitalized with HF

    Ethn Dis

    (2005)
  • J.E. Sanderson et al.

    HF: A global disease requiring a global response

    Heart

    (2003)
  • D.K. Tso et al.

    Cardiovascular disease in Chinese Canadians: A case-mix study from an urban tertiary care cardiology clinic

    Can J Cardiol

    (2002)
  • H. Jiang et al.

    Epidemiology and clinical management of cardiomyopathies and HF in China

    Heart

    (2009)
  • G.W. Yip et al.

    The Hong Kong diastolic heart failure study: A randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in HF with a normal ejection fraction

    Heart

    (2008)
  • W.K. Chan et al.

    A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors

    Eur J Clin Pharmacol

    (1993)
  • J. Woo et al.

    A high incidence of cough associated with combination therapy of hypertension with isradipine and lisinopril in Chinese subjects

    Br J Clin Pract

    (1991)
  • Cited by (0)

    1

    Primary panelists

    View full text